Zhao Y, Zhang L, Zhang J. Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial. J Am Acad Dermatol 2024 Jul 20:S0190-9622(24)02498.
PMID: 39038559